SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Overview
Europe - FRA:56S1 - FR0013154002 - Common Stock
56S1.DE Key Statistics, Chart & Performance
The current stock price of 56S1.DE is 195.2 EUR. In the past month the price increased by 10.5%. In the past year, price increased by 1.59%.
56S1.DE Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| TN8.DE | THERMO FISHER SCIENTIFIC INC | 24.41 | 172.00B | ||
| DAP.DE | DANAHER CORP | 28.66 | 131.75B | ||
| 1DHR.MI | DANAHER CORP | 28.66 | 131.68B | ||
| LO3.DE | LONZA GROUP AG-REG | 35.74 | 41.65B | ||
| QTS.DE | IQVIA HOLDINGS INC | 17.93 | 29.81B | ||
| DIM.PA | SARTORIUS STEDIM BIOTECH | 48.09 | 19.33B | ||
| SRT3.DE | SARTORIUS AG-VORZUG | 52.64 | 17.15B | ||
| SRT.DE | SARTORIUS AG | 42.34 | 13.79B | ||
| ILU.DE | ILLUMINA INC | 24.02 | 13.11B | ||
| ERF.PA | EUROFINS SCIENTIFIC | 17.47 | 11.46B | ||
| ESF0.DE | EUROFINS SCIENTIFIC | 17.25 | 11.31B | ||
| QIA.DE | QIAGEN N.V. | 19.87 | 8.62B |
Related stock screener links
About 56S1.DE
Company Profile
Sartorius Stedim Biotech SA provides equipment and services for the development, quality assurance, and production processes of the biopharmaceutical industry. The company is headquartered in Aubagne, Paca and currently employs 10,030 full-time employees. The firm covers the segments of biotechnology and mechatronics. Sartorius provides services which help customers to implement complex and quality-critical processes in biopharmaceutical production and laboratory environments in a time- and cost-efficient way. The Company’s customers are from the biotech, pharma and food industries, as well as from public research institutes and laboratories. Sartorius operates its own production facilities in Europe, Asia and America, and also has sales offices and local representatives in more than 110 countries. The firm operates through its subsidiaries, including Sartorius Stedim Austria GmbH, Sartorius Stedim Plastics GmbH, BioOutsource Ltd and Wave Biotech AG, among others.
Company Info
SARTORIUS STEDIM BIOTECH
Zone Industrielle les Paluds Avenue de Jouques, Bp 1051, Aubagne Cedex
Aubagne PACA FR
Employees: 10030
Phone: 33442845600
SARTORIUS STEDIM BIOTECH / 56S1.DE FAQ
What is the stock price of SARTORIUS STEDIM BIOTECH today?
The current stock price of 56S1.DE is 195.2 EUR. The price increased by 2.63% in the last trading session.
What is the ticker symbol for SARTORIUS STEDIM BIOTECH stock?
The exchange symbol of SARTORIUS STEDIM BIOTECH is 56S1 and it is listed on the Deutsche Boerse Ag exchange.
On which exchange is 56S1.DE stock listed?
56S1.DE stock is listed on the Deutsche Boerse Ag exchange.
What is the price forecast or stock price prediction for SARTORIUS STEDIM BIOTECH stock?
18 analysts have analysed 56S1.DE and the average price target is 239.46 EUR. This implies a price increase of 22.67% is expected in the next year compared to the current price of 195.2. Check the SARTORIUS STEDIM BIOTECH stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is SARTORIUS STEDIM BIOTECH worth?
SARTORIUS STEDIM BIOTECH (56S1.DE) has a market capitalization of 19.00B EUR. This makes 56S1.DE a Large Cap stock.
How many employees does SARTORIUS STEDIM BIOTECH have?
SARTORIUS STEDIM BIOTECH (56S1.DE) currently has 10030 employees.
What are the support and resistance levels for SARTORIUS STEDIM BIOTECH (56S1.DE) stock?
SARTORIUS STEDIM BIOTECH (56S1.DE) has a support level at 184.54 and a resistance level at 195.21. Check the full technical report for a detailed analysis of 56S1.DE support and resistance levels.
Is SARTORIUS STEDIM BIOTECH (56S1.DE) expected to grow?
The Revenue of SARTORIUS STEDIM BIOTECH (56S1.DE) is expected to grow by 9.03% in the next year. Check the estimates tab for more information on the 56S1.DE EPS, Sales, EBIT and EBITDA future analyst estimates.
Should I buy SARTORIUS STEDIM BIOTECH (56S1.DE) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of 56S1.DE, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of 56S1.DE, evaluating the profitability, health, valuation and growth aspects
- SARTORIUS STEDIM BIOTECH (56S1.DE) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- SARTORIUS STEDIM BIOTECH (56S1.DE) Sales and EPS estimates to see what analysts future expectations are.
- SARTORIUS STEDIM BIOTECH (56S1.DE) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- SARTORIUS STEDIM BIOTECH (56S1.DE) Insider and Institutional Ownership to learn about the owners and their transactions.
- SARTORIUS STEDIM BIOTECH (56S1.DE) Stock Chart to make your own analysis
- SARTORIUS STEDIM BIOTECH (56S1.DE) Latest news and press-releases to stay up to date.
Does SARTORIUS STEDIM BIOTECH (56S1.DE) stock pay dividends?
SARTORIUS STEDIM BIOTECH (56S1.DE) has a dividend yield of 0.36%. The yearly dividend amount is currently 0.71. Check the full fundamental report for a detailed analysis of 56S1.DE dividend history, reliability and sustainability.
When does SARTORIUS STEDIM BIOTECH (56S1.DE) report earnings?
SARTORIUS STEDIM BIOTECH (56S1.DE) will report earnings on 2025-10-16.
What is the Price/Earnings (PE) ratio of SARTORIUS STEDIM BIOTECH (56S1.DE)?
The PE ratio for SARTORIUS STEDIM BIOTECH (56S1.DE) is 47.26. This is based on the reported non-GAAP earnings per share of 4.13 and the current share price of 195.2 EUR. Check the full fundamental report for a full analysis of the valuation metrics for 56S1.DE.
56S1.DE Technical Analysis
ChartMill assigns a technical rating of 4 / 10 to 56S1.DE. When comparing the yearly performance of all stocks, 56S1.DE is a bad performer in the overall market: 69.69% of all stocks are doing better.
56S1.DE Fundamental Analysis
ChartMill assigns a fundamental rating of 5 / 10 to 56S1.DE. Both the profitability and the financial health of 56S1.DE get a neutral evaluation. Nothing too spectacular is happening here.
56S1.DE Financial Highlights
Over the last trailing twelve months 56S1.DE reported a non-GAAP Earnings per Share(EPS) of 4.13. The EPS increased by 25.91% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | 7.78% | ||
| ROA | 2.71% | ||
| ROE | 5.63% | ||
| Debt/Equity | 0.71 |
56S1.DE Forecast & Estimates
18 analysts have analysed 56S1.DE and the average price target is 239.46 EUR. This implies a price increase of 22.67% is expected in the next year compared to the current price of 195.2.
For the next year, analysts expect an EPS growth of 27.61% and a revenue growth 9.03% for 56S1.DE